Punicalagin, an active component in pomegranate, ameliorates cardiac mitochondrial impairment in obese rats via AMPK activation

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Cao, Ke ^a   Xu, Jie ^a   Pu, Wenjun ^a   Dong, Zhizhong ^b   Sun, Lei ^a   Zang, Weijin ^a   Gao, Feng ^c   Zhang, Yong ^a,d   Feng, Zhihui ^a   Liu, Jiankang ^a,d  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d TIANJIN UNIVERSITY OF SPORT   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PUNICALAGIN; TANNIN;

ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CHEMISTRY; DRUG EFFECTS; HEART MITOCHONDRION; LIPID DIET; LYTHRACEAE; METABOLISM; OBESITY; ORGANELLE BIOGENESIS; OXIDATIVE STRESS; PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DIET, HIGH-FAT; HYDROLYZABLE TANNINS; MITOCHONDRIA, HEART; MYOCARDIUM; MYOCYTES, CARDIAC; OBESITY; ORGANELLE BIOGENESIS; OXIDATIVE STRESS; PHOSPHORYLATION; PUNICACEAE; RATS; SIGNAL TRANSDUCTION;

EID: 84941695345     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14014     Document Type: Article

References (48)

1. Barness, L. A., Opitz, J. M. & Gilbert-Barness, E. Obesity: genetic, molecular, and environmental aspects. Am J Med Genet A 143A, 3016-3034, doi: 10.1002/ajmg.a.32035 (2007).
2. Harmancey, R., Wilson, C. R. & Taegtmeyer, H. Adaptation and maladaptation of the heart in obesity. Hypertension 52, 181-187, doi: 10.1161/HYPERTENSIONAHA.108.110031 (2008).
3. Louwe, M. C., et al. Gender-dependent effects of high-fat lard diet on cardiac function in C57Bl/6J mice. Appl Physiol Nutr Metab 37, 214-224, doi: 10.1139/h11-153 (2012).
4. Schram, K. & Sweeney, G. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure. Trends Cardiovasc Med 18, 199-205, doi: 10.1016/j.tcm.2008.10.001 (2008).
5. Lamounier-Zepter, V., et al. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 105, 326-334, doi: 10.1161/CIRCRESAHA.109.200501 (2009).
6. Martinez-Martinez, E., et al. Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: potential role in obesity. J Hypertens 32, 1104-1114; discussion 1114, doi: 10.1097/HJH.0000000000000149 (2014).
7. Ndisang, J. F., Vannacci, A. & Rastogi, S. Oxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complications. Oxid Med Cell Longev 2014, 506948, doi: 10.1155/2014/506948 (2014).
8. Niemann, B., et al. Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J Am Coll Cardiol 57, 577-585, doi: 10.1016/j.jacc.2010.09.040 (2011).
9. Muthulakshmi, S. & Saravanan, R. Protective effects of azelaic acid against high-fat diet-induced oxidative stress in liver, kidney and heart of C57BL/6J mice. Mol Cell Biochem 377, 23-33, doi: 10.1007/s11010-013-1566-1 (2013).
10. Vial, G., et al. Effects of a high-fat diet on energy metabolism and ROS production in rat liver. J Hepatol 54, 348-356, doi: 10.1016/j.jhep.2010.06.044 (2011).
11. Zong, H., et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci USA 99, 15983-15987, doi: 10.1073/pnas.252625599 (2002).
12. Bergeron, R., et al. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab 281, E1340-1346 (2001).
13. Lindholm, C. R., et al. A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats. J Physiol Biochem 69, 165-175, doi: 10.1007/s13105-012-0199-2 (2013).
14. Shao, D., et al. A redox-dependent mechanism for regulation of AMPK activation by Thioredoxin1 during energy starvation. Cell Metab 19, 232-245, doi: 10.1016/j.cmet.2013.12.013 (2014).
15. Turdi, S., et al. Deficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction. J Mol Cell Cardiol 50, 712-722, doi: 10.1016/j.yjmcc.2010.12.007 (2011).
16. Onken, B. & Driscoll, M. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PloS One 5, e8758, doi: 10.1371/journal.pone.0008758 (2010).
17. Liu, X. M., et al. Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. Am J Physiol Heart Circ Physiol 300, H84-93, doi: 10.1152/ajpheart.00749.2010 (2011).
18. Mo, C., et al. The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid Redox Signal 20, 574-588, doi: 10.1089/ars.2012.5116 (2014).
19. Cao, K., et al. AMPK activation prevents prenatal stress-induced cognitive impairment: Modulation of mitochondrial content and oxidative stress. Free Radic Biol Med 75C, 156-166, doi: S0891-5849(14)00346-3 (2014).
20. Gil, M. I., Tomas-Barberan, F. A., Hess-Pierce, B., Holcroft, D. M. & Kader, A. A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 48, 4581-4589, doi: jf000404a (2000).
21. Aviram, M., et al. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res 28, 49-62 (2002).
22. Esmaillzadeh, A., Tahbaz, F., Gaieni, I., Alavi-Majd, H. & Azadbakht, L. Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia. J Med Food 7, 305-308, doi: 10.1089/1096620041938623 (2004).
23. Huang, T. H., et al. Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids. Br J Pharmacol 145, 767-774, doi: 0706245 (2005).
24. Huang, T. H., et al. Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways. J Cardiovasc Pharmacol 46, 856-862, doi: 00005344-200512000-00021 (2005).
25. Singh, M., et al. Influence of the solvents on the extraction of major phenolic compounds (punicalagin, ellagic acid and gallic acid) and their antioxidant activities in pomegranate aril. J Food Sci Technol 51, 2070-2077, doi: 10.1007/s13197-014-1267-0 (2014).
26. Lin, C. C., Hsu, Y. F. & Lin, T. C. Effects of punicalagin and punicalin on carrageenan-induced inflammation in rats. Am J Chin Med 27, 371-376, doi: 10.1142/S0192415? 99000422 (1999).
27. Aoyagi, T., et al. Cardiac mTOR rescues the detrimental effects of diet-induced obesity in the heart after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 308, H1530-1539, doi: 10.1152/ajpheart.00008.2015 (2015).
28. Yadav, H. N., Singh, M. & Sharma, P. L. Involvement of GSK-3beta in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart. Mol Cell Biochem 343, 75-81, doi: 10.1007/s11010-010-0500-z (2010).
29. Jager, S., Handschin, C., St-Pierre, J. & Spiegelman, B. M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA 104, 12017-12022, doi: 10.1073/pnas.0705070104 (2007).
30. Venturini, D., et al. Evaluation of oxidative stress in overweight subjects with or without metabolic syndrome. Obesity (Silver Spring) 20, 2361-2366, doi: 10.1038/oby.2012.130 (2012).
31. Eckel, R. H., Barouch, W. W. & Ershow, A. G. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease. Circulation 105, 2923-2928 (2002).
32. Wang, Z., Li, L., Zhao, H., Peng, S. & Zuo, Z. Chronic high fat diet induces cardiac hypertrophy and fibrosis in mice. Metabolism 64, 917-925, doi: 10.1016/j.metabol.2015.04.010 (2015).
33. Kuwabara, Y., et al. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. Circ Res 116, 279-288, doi: 10.1161/CIRCRESAHA.116.304707 (2015).
34. Yuan, F., et al. Moderate ethanol administration accentuates cardiomyocyte contractile dysfunction and mitochondrial injury in high fat diet-induced obesity. Toxicol Lett 233, 267-277, doi: 10.1016/j.toxlet.2014.12.018 (2015).
35. Xia, Y., et al. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy. Mol Cell Endocrinol 403, 21-29, doi: 10.1016/j.mce.2015.01.014 (2015).
36. Nduhirabandi, F., Huisamen, B., Strijdom, H., Blackhurst, D. & Lochner, A. Short-term melatonin consumption protects the heart of obese rats independent of body weight change and visceral adiposity. J Pineal Res 57, 317-332, doi: 10.1111/jpi.12171 (2014).
37. Cerda, B., Ceron, J. J., Tomas-Barberan, F. A. & Espin, J. C. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J Agric Food Chem 51, 3493-3501, doi: 10.1021/jf020842c (2003).
38. Zou, X., et al. Mitochondrial Dysfunction in Obesity-Associated Nonalcoholic Fatty Liver Disease: The Protective Effects of Pomegranate with Its Active Component Punicalagin. Antioxid Redox Signal, doi: 10.1089/ars.2013.5538 (2014).
39. Hardie, D. G. Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. FEBS Lett 582, 81-89, doi: 10.1016/j.febslet.2007.11.018 (2008).
40. Zhang, B. B., Zhou, G. & Li, C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 9, 407-416, doi: 10.1016/j.cmet.2009.03.012 (2009).
41. Turdi, S., et al. AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction. Aging cell 9, 592-606, doi: 10.1111/j.1474-9726.2010.00586.x (2010).
42. Kukidome, D., et al. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 55, 120-127 (2006).
43. Tedesco, L., et al. Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes. Diabetes 57, 2028-2036, doi: 10.2337/db07-1623 (2008).
44. Sebastian, D., et al. Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl Acad Sci USA 109, 5523-5528, doi: 10.1073/pnas.1108220109 (2012).
45. James, D. I. & Martinou, J. C. Mitochondrial dynamics and apoptosis: a painful separation. Dev Cell 15, 341-343, doi: 10.1016/j. devcel.2008.08.011 (2008).
46. Sugioka, R., Shimizu, S. & Tsujimoto, Y. Fzo1, a protein involved in mitochondrial fusion, inhibits apoptosis. J Biol Chem 279, 52726-52734, doi: 10.1074/jbc.M408910200 (2004).
47. Chavin, K. D., et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 274, 5692-5700 (1999).
48. Kodama, H., et al. Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 81, 656-663 (1997).